Novel therapeutic approaches in chronic myeloid leukemia.


Özgür Y., Eşkazan A. E.

Leukemia research, vol.91, pp.106337, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 91
  • Publication Date: 2020
  • Doi Number: 10.1016/j.leukres.2020.106337
  • Journal Name: Leukemia research
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.106337
  • Keywords: Asciminib, BCR-ABL1, Chronic myeloid leukemia, Novel therapy, Tyrosine kinase inhibitor, CHRONIC MYELOGENOUS LEUKEMIA, FARNESYL TRANSFERASE INHIBITOR, TREATMENT-FREE REMISSION, LOW-DOSE DECITABINE, CML CD34(+) CELLS, BCR-ABL, CHRONIC-PHASE, IMATINIB MESYLATE, AURORA KINASE, RESIDUAL DISEASE
  • Istanbul University-Cerrahpasa Affiliated: Yes